UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 719

Sortiert nach

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1109-1120

2019

Volltextzugriff (PDF)

Bio‐based hydroxymethylated eugenol modified bismaleimide resin and its high‐temperature composites

Journal of applied polymer science, 2021-01, Vol.138 (1), p.n/a

2021

Volltextzugriff (PDF)

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

Alimentary pharmacology & therapeutics, 2018-12, Vol.48 (11-12), p.1290-1300

2018

Volltextzugriff (PDF)

21st-century rise in anthropogenic nitrogen deposition on a remote coral reef

Science (American Association for the Advancement of Science), 2017-05, Vol.356 (6339), p.749-752

2017

Volltextzugriff (PDF)

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B

Liver international, 2023-01, Vol.43 (1), p.77-89

2023

Volltextzugriff (PDF)

Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals

Journal of medical virology, 2024-05, Vol.96 (5), p.e29675-n/a

2024

Volltextzugriff (PDF)

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

The Lancet infectious diseases, 2021-06, Vol.21 (6), p.823-833

2021

Volltextzugriff (PDF)

Source apportionment and evolution of N-containing aerosols at a rural cloud forest in Taiwan by isotope analysis

Atmospheric chemistry and physics, 2022-10, Vol.22 (19), p.13001-13012

2022

Volltextzugriff (PDF)

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan

Journal of gastroenterology and hepatology, 2022-10, Vol.37 (10), p.1901-1910

2022

Volltextzugriff (PDF)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

BMC infectious diseases, 2022-04, Vol.22 (1), p.351-351, Article 351

2022

Volltextzugriff (PDF)

Phytochemical and anti-MRSA constituents of Zanthoxylum nitidum

Biomedicine & pharmacotherapy, 2022-04, Vol.148, p.112758-112758, Article 112758

2022

Volltextzugriff (PDF)

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study

Journal of gastroenterology and hepatology, 2018-08, Vol.33 (8), p.1507-1510

2018

Volltextzugriff (PDF)

miR‐346 and miR‐582‐3p‐regulated EG‐VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9

BioFactors (Oxford), 2017-03, Vol.43 (2), p.210-219

2017

Volltextzugriff (PDF)

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (2), p.217-229

2024

Volltextzugriff (PDF)

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Oncotarget, 2018-01, Vol.9 (4), p.4637-4646

2018

Volltextzugriff (PDF)

Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection

Journal of viral hepatitis, 2020-08, Vol.27 (8), p.800-809

2020

Volltextzugriff (PDF)

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

Journal of gastroenterology and hepatology, 2019-11, Vol.34 (11), p.1977-1983

2019

Volltextzugriff (PDF)

A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment

Journal of the Formosan Medical Association, 2024-01, Vol.123 (1), p.55-61

2024

Volltextzugriff (PDF)

Nonlinear climatic sensitivity to greenhouse gases over past 4 glacial/interglacial cycles

Scientific reports, 2017-07, Vol.7 (1), p.4626-7, Article 4626

2017

Volltextzugriff (PDF)

Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis

Helicobacter (Cambridge, Mass.), 2022-10, Vol.27 (5), p.e12914-n/a

2022

Volltextzugriff (PDF)

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Journal of microbiology, immunology and infection, 2021-06, Vol.54 (3), p.385-395

2021

Volltextzugriff (PDF)

Efficacy and Safety of Exploring Deeper Sections of the Infrapapillary Area of the Duodenum by Using Sedative Esophagogastroduodenoscopy

Gastroenterology research and practice, 2022-07, Vol.2022, p.1-8

2022

Volltextzugriff (PDF)

Hypoglycemic effects of dracorhodin and dragon blood crude extract from Daemonorops draco

Botanical studies, 2024-03, Vol.65 (1), p.8-8, Article 8

2024

Volltextzugriff (PDF)

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma

Cancers, 2021-10, Vol.13 (21), p.5303

2021

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(559)
Mit Volltextzugriff
(658)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Bio‐based hydroxymethylated eugenol modified bismaleimide resin and its high‐temperature composites

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

21st-century rise in anthropogenic nitrogen deposition on a remote coral reef

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

Source apportionment and evolution of N-containing aerosols at a rural cloud forest in Taiwan by isotope analysis

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Phytochemical and anti-MRSA constituents of Zanthoxylum nitidum

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study

miR‐346 and miR‐582‐3p‐regulated EG‐VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression

Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment

Nonlinear climatic sensitivity to greenhouse gases over past 4 glacial/interglacial cycles

Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Efficacy and Safety of Exploring Deeper Sections of the Infrapapillary Area of the Duodenum by Using Sedative Esophagogastroduodenoscopy

Hypoglycemic effects of dracorhodin and dragon blood crude extract from Daemonorops draco

The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma

Suchergebnisse filtern